| Product Code: ETC10401774 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Recombinant DNA rDNA Technology Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Recombinant DNA rDNA Technology Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Recombinant DNA rDNA Technology Market - Industry Life Cycle |
3.4 Ireland Recombinant DNA rDNA Technology Market - Porter's Five Forces |
3.5 Ireland Recombinant DNA rDNA Technology Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Ireland Recombinant DNA rDNA Technology Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Ireland Recombinant DNA rDNA Technology Market Revenues & Volume Share, By End-Use, 2021 & 2031F |
4 Ireland Recombinant DNA rDNA Technology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and biopharmaceuticals |
4.2.2 Growing investments in research and development within the biotechnology sector |
4.2.3 Favorable government initiatives and policies supporting biotechnology innovation in Ireland |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and compliance standards in the biotechnology industry |
4.3.2 Limited skilled workforce and expertise in recombinant DNA technology |
4.3.3 High costs associated with setting up and maintaining recombinant DNA technology facilities |
5 Ireland Recombinant DNA rDNA Technology Market Trends |
6 Ireland Recombinant DNA rDNA Technology Market, By Types |
6.1 Ireland Recombinant DNA rDNA Technology Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Recombinant DNA rDNA Technology Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Ireland Recombinant DNA rDNA Technology Market Revenues & Volume, By Therapeutic Agents, 2021 - 2031F |
6.1.4 Ireland Recombinant DNA rDNA Technology Market Revenues & Volume, By Genetically Modified Crops, 2021 - 2031F |
6.1.5 Ireland Recombinant DNA rDNA Technology Market Revenues & Volume, By Vaccines, 2021 - 2031F |
6.2 Ireland Recombinant DNA rDNA Technology Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Ireland Recombinant DNA rDNA Technology Market Revenues & Volume, By Drug Development, 2021 - 2031F |
6.2.3 Ireland Recombinant DNA rDNA Technology Market Revenues & Volume, By Agriculture, 2021 - 2031F |
6.2.4 Ireland Recombinant DNA rDNA Technology Market Revenues & Volume, By Disease Prevention, 2021 - 2031F |
6.3 Ireland Recombinant DNA rDNA Technology Market, By End-Use |
6.3.1 Overview and Analysis |
6.3.2 Ireland Recombinant DNA rDNA Technology Market Revenues & Volume, By Pharmaceuticals, 2021 - 2031F |
6.3.3 Ireland Recombinant DNA rDNA Technology Market Revenues & Volume, By Agriculture, 2021 - 2031F |
6.3.4 Ireland Recombinant DNA rDNA Technology Market Revenues & Volume, By Healthcare, 2021 - 2031F |
7 Ireland Recombinant DNA rDNA Technology Market Import-Export Trade Statistics |
7.1 Ireland Recombinant DNA rDNA Technology Market Export to Major Countries |
7.2 Ireland Recombinant DNA rDNA Technology Market Imports from Major Countries |
8 Ireland Recombinant DNA rDNA Technology Market Key Performance Indicators |
8.1 Research and development (RD) expenditure in the biotechnology sector |
8.2 Number of patents granted for recombinant DNA technology innovations |
8.3 Percentage of biotechnology graduates entering the workforce |
8.4 Investment flow into biotechnology startups in Ireland |
8.5 Number of collaborations and partnerships in the recombinant DNA technology market |
9 Ireland Recombinant DNA rDNA Technology Market - Opportunity Assessment |
9.1 Ireland Recombinant DNA rDNA Technology Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Ireland Recombinant DNA rDNA Technology Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Ireland Recombinant DNA rDNA Technology Market Opportunity Assessment, By End-Use, 2021 & 2031F |
10 Ireland Recombinant DNA rDNA Technology Market - Competitive Landscape |
10.1 Ireland Recombinant DNA rDNA Technology Market Revenue Share, By Companies, 2024 |
10.2 Ireland Recombinant DNA rDNA Technology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here